Integra LifeSciences IART Tissue Reconstruction — Foreign currency translation

Other segment segments

Specialty Surgery

-$1.07M—

Similar metrics at other companies

ABMTechnical Solutions — Foreign currency translation

$75K-72.7%

VNTRepair Solutions — Foreign currency translation and other

$0—

FCNTechnology — Foreign currency translation adjustment

-$30K-171%

AFLCancer — Foreign currency translation and other

-$62M-139%

BAXHealthcare Systems & Technologies — Currency translation and other

$5.5M+257%

DOVImaging & Identification — Foreign currency translation

-$7.92M-155%

Other financials

Income statement

See full

Revenue$391.9M+2.4%

Gross profit$217.0M+11.6%

Operating income$11.5M+174%

Net income-$4.6M+81.7%

EPS (diluted)-$0.06+81.8%

Balance sheet

See full

Cash & equivalents$236.8M-1.0%

Total debt$2.0B+3.2%

Total equity$1.0B-31.6%

Total assets$3.6B-11.7%

Cash flow

See full

Operating cash flow$9.8M+187%

CapEx$14.8M-48.7%

Free cash flow-$5.0M+87.4%

Valuation

See full

Market cap$1.38B+53.4%

Enterprise value$3.12B+21.1%

P/S0.8×+0.3×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin-29.8%-30.3pp

Net margin-30.1%—

FCF margin3.8%-6.3pp

Returns & leverage

See full

Return on equity-38.6%—

Debt / equity1.9×+0.6×

Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's tissue reconstruction — foreign currency translation.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Integra LifeSciences's tissue reconstruction — foreign currency translation?: Integra LifeSciences (IART) reported tissue reconstruction — foreign currency translation of -$841K in Q1 2026.
What does tissue reconstruction — foreign currency translation mean?: This captures the impact of fluctuations in foreign exchange rates on the financial results of the Tissue Reconstruction segment. It highlights the segment's exposure to international markets and the volatility associated with non-domestic operations.